University of Malawi delegates visit Glasgow

University of Malawi Delegates Visit

A delegation from the College of Medicine, Malawi, visited the Institute infection, Immunity and inflammation and Wellcome Centre for Molecular Parasitology for a week’s long training programme at the beginning of December.

The group included newly appointed staff from the Blantyre—Blantyre Clinical research lab, a facility being set up in partnership with University of Glasgow, funded directly with £1million from the Scottish Government, and match funded to £2million by the World Bank and the Wellcome Trust.

The delegation undertook training on laboratory information and financial systems, meeting with University of Glasgow commercial, Intellectual Property, financial and IT staff who were able to offer advice on best practice.

A visit to the Queen Elizabeth University Hospital biochemistry diagnostic lab, and life sciences company Reprocell, provided them with a wealth of ideas to take back to Malawi.

Hosting the delegation in were Professor Paul Garside, Institute of infection Immunity & Inflammation  Global Health Lead, Professor Andy Waters, Director of the Wellcome Centre for Molecular Parasitology and Professor Iain McInnes, Director of the Institute Infection, Immunity & inflammation.

Professor Andy Waters said: “The visit of the working Malawi delegation represents the next concrete step In the Blantyre-Blantyre project, providing an opportunity for the necessary training and exposure to best practice in Glasgow, that we are confident will be expertly deployed back home by the team. It was also great to meet them and start building real working relationships.”

Professor Paul Garside added: “a great training and team building week with our colleagues from Malawi as we build the infrastructure and skills to deliver the Blantyre-Blantyre project.”

Professor Iain McInnes said: “The University of Glasgow is proud to be working so closely with our colleagues in the College of Medicine in Malawi. 

“Together we seek to improve the lives of those afflicted by a variety of chronic infectious and non-communicable diseases that can now be far better managed than ever before.  Working together we will achieve our goals more quickly and more effectively.”


First published: 4 December 2017